
Identifying high-risk HPV infections starts with the right test. Dr. Kyle Bukowski, Hologic’s Medical Director, explains how the Aptima® HPV Assay targets E6/E7 mRNA focusing on genotypes 16, 18 & 45—linked to up to 92% of cervical adenocarcinomas.
Watch:
ow.ly/Zxce50ZiKNl
English



























